A lawsuit was filed on behalf of investors in Genocea Biosciences Inc (NASDAQ:GNCA) shares over alleged securities laws violations.
San Diego, CA -- (SBWIRE) -- 11/28/2017 -- An investor in NASDAQ:GNCA shares filed a lawsuit against Genocea Biosciences Inc over alleged violations of Federal Securities Laws by Genocea Biosciences Inc.
Investors who purchased shares of Genocea Biosciences Inc (NASDAQ:GNCA) should contact the Shareholders Foundation at email@example.com or call 858-779-1554.
The plaintiff claims that between May 5, 2017 and September 25, 2017, the Defendants made false and/or misleading statements and/or failed to disclose that the Company's finances were insufficient to support Phase 3 trials of GEN-003, that accordingly, Genocea had overstated the prospects for GEN-003, and that as a result of the foregoing, Genocea's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Genocea Biosciences Inc (NASDAQ:GNCA) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels